GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2376 - 2400** of **4050** in total

« First

‹ Prev

…

92

93

94

95

96

97

98

99

100

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgM	Patient 1	10	moderate	G53168IY	58
IgM	Patient 1	22	moderate	G53168IY	217
IgA	Patient 2	15	mild	G53168IY	606
IgA	Patient 2	24	mild	G53168IY	710
IgG	Patient 2	15	mild	G53168IY	58
IgG	Patient 2	24	mild	G53168IY	59
IgM	Patient 2	15	mild	G53168IY	291
IgM	Patient 2	24	mild	G53168IY	308
IgG	Patient 1	6	moderate	G53168IY	25
IgM	Patient 1	6	moderate	G53168IY	53
IgA	Patient 2	3	mild	G53168IY	755
IgG	Patient 2	3	mild	G53168IY	77
IgM	Patient 2	3	mild	G53168IY	440
IgA	Patient 3	-180	mild	G53168IY	271
IgA	Patient 3	11	mild	G53168IY	426
IgG	Patient 3	-180	mild	G53168IY	40
IgM	Patient 3	-180	mild	G53168IY	74
IgA	Patient 3	4	mild	G53168IY	410
IgG	Patient 3	11	mild	G53168IY	44
IgG	Patient 3	4	mild	G53168IY	42
IgM	Patient 3	11	mild	G53168IY	140
IgM	Patient 3	4	mild	G53168IY	131
IgA	Patient 4	12	mild	G53168IY	660
IgG	Patient 4	12	mild	G53168IY	151
IgM	Patient 4	12	mild	G53168IY	1104